Simplexa Covid-19 Direct Assay
Simplexa COVID-19 Direct Assay Recall The Simplexa COVID-19 Direct Assay, a COVID-19 test product, is being recalled across Canada due to a manufacturing defect. This is a Class I recall, the most serious classification. The defect affects all units distributed in Canada.
- Product
- Simplexa Covid-19 Direct Assay
- Reason
- Manufacturing defect
- Classification
- Class I
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DEVICES
- Recall date
- 2022-01-10
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-DEVICES
Recall details on Nibble Recalls: https://trynibble.app/recalls/3ab64990-d942-4943-aa00-d7942be904c6